Clinical And Genetic Markers Of Erythropoietin Deficiency Anemia In Chronic Kidney Disease (Predialysis) Patients

Aim: To determine the clinical and genetic markers associated with erythropoietin deficiency anemia in predialysis individuals. Materials & methods: Patients were categorized into cases and control group. Demographic characteristics and clinical parameters were obtained from medical record review and serum EPO and ferritin were obtained with ELISA.HIF-1 alpha (rs2057482),IL-1 beta (rs1143627) and EPO (rs1617640) gene polymorphism were genotyped. Results: Female gender, glomerular filtration rate, treatment with hematinics, anticoagulant and diuretic were strong predictors of EPO-deficient anemia in predialysis chronic kidney disease patients. Genetic polymorphism in the HIF-1 alpha recessive model was associated with non-EPO-deficiency, followed byEPOrecessive allele associated with low-serum erythropoietin andIL-1 beta recessive model with low hemoglobin level. Conclusion: EPO-deficiency anemia can be diagnosed more conveniently in the presence of biomarkers.